Cryo-Cell International, Inc. CCEL
AMEX
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -310.81% | -1,340.60% | -2,169.18% | -704.15% | 94.70% |
| Total Depreciation and Amortization | -2.05% | 0.97% | 14.14% | 33.92% | 26.11% |
| Total Amortization of Deferred Charges | -1.91% | -1.90% | -1.90% | -1.89% | -1.88% |
| Total Other Non-Cash Items | 62.52% | 160.57% | 234.65% | 325.60% | -80.79% |
| Change in Net Operating Assets | -33.87% | 5.90% | -43.35% | -23.31% | -26.91% |
| Cash from Operations | -22.57% | 0.96% | -29.30% | -8.86% | -11.72% |
| Capital Expenditure | -56.70% | 35.38% | 88.27% | 90.41% | 95.83% |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 91.55% | 131.92% | 80.53% | 65.24% | -6.87% |
| Cash from Investing | 76.89% | 124.33% | 86.14% | 80.00% | 68.63% |
| Total Debt Issued | -63.72% | -63.72% | 1.84% | 68.58% | 175.63% |
| Total Debt Repaid | 17.74% | -52.25% | -124.32% | -232.36% | -107.50% |
| Issuance of Common Stock | -76.35% | -39.27% | -69.76% | -69.76% | 9,750.00% |
| Repurchase of Common Stock | 100.00% | 22.95% | 86.48% | 88.10% | 88.10% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | 100.00% | 70.04% | -59.92% | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 25.46% | -125.98% | -77.64% | -384.64% | -143.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,611.50% | 211.46% | 210.42% | -256.27% | 117.54% |